Author： Nathan Herrmann Krista L. Lanctôt
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.19, Iss.2, 2005-01, pp. : 91-103
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Off-Label Use of Atypical Antipsychotics: Cause for Concern?
CNS Drugs, Vol. 26, Iss. 5, 2012-05 ,pp. :
Access to resources
Recommend
Atypical antipsychotics cause diabetes mellitus in schizophrenia?
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Statins: how do they prevent stroke?
Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. :
What's new with alteplase in stroke?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
`Doom and gloom' for neuroprotectants in stroke?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :